←
Cancer Trials Mater121 posts
Cancer Trials Mater avatar

Cancer Trials Mater

@MaterTrials

Clinical Trials&Research Unit (CTRU) @materdublin & @materprivate. Passionate about research & improving patient outcomes in 🇮🇪 CRA: 20000349 RCN:CHY20000349

◷ Joined July 2021▧ 15 Photos and videos
Cancer Trials Mater avatar
Cancer Trials Mater@MaterTrials·16 Nov 2022

Hello 👋👋👋 from our Clinical Trials & Research Unit team @MaterDublin Our team is made up of consultant hematologists & oncologists, nurses, pharmacists, data managers, business managers, and administrators. We all work together to enable patients to access clinical trials

Post attachment
Cancer Trials Mater avatar
Cancer Trials Mater@MaterTrials·29 Jun 2023

Delighted to report that the 1st patient has been recruited to the PaTcH study at The Mater. This is for patients with advanced pancreatic cancer! (Study details: bit.ly/3rbsLjq) Enormous congrats to the team involved and everyone who supports the Pat Smullen Fund!

Post attachment
Cancer Trials Mater avatar
Cancer Trials Mater@MaterTrials·19 May 2023

Delighted to have been part of this exciting clinical trial at The Mater with PI Dr. Anne Fortune. #ucdcancertrials #CancerResearch #clinicaltrials

We are so pleased for - and proud of - the team in @CancerTrials_ie & at trial sites for all they contributed to this prestigious @NEJM publication! Particular congrats to our Chief Investigator Prof Patrick Thornton - one of the study's authors (Go here: bit.ly/41xBJ7c) @Seamusoreilly18 @RayMcDermott1

Post attachment
Cancer Trials Mater avatar
Cancer Trials Mater@MaterTrials·19 Jan 2023

🎇 2022 accrual figures 🎇 We recruited 2⃣7⃣ patients to interventional trials & over 1⃣4⃣0⃣ to translational trials. Our recruitment to interventional trials has increased in comparison to 2021! Thank you to our patients for taking part and well done to our team 🎉🎉🎉

Cancer Trials Mater avatar
Cancer Trials Mater@MaterTrials·11 Jan 2023

🌎Mirati trial is open ▶️ This is for patients with advanced colorectal cancer who have the KRAS G12C mutation & have received one line of treatment 💉 We are checking if the drug,adagrasib, in combination with cetuximab works more effectively in comparison to chemotherapy

Cancer Trials Mater avatar
Cancer Trials Mater@MaterTrials·7 Dec 2022

More data from TAILORX "Long-term clinical outcomes continue to show that many women with early breast cancer can safely forego chemotherapy." We recruited 96 patients for this study ecog-acrin.org/press-release…

Clodagh Downing avatar
⟳ Cancer Trials Mater retweeted
Clodagh Downing@ClodaghDowning·6 Dec 2022

For patients w/ #ColorectalCancer : There's a new Facebook group providing a forum for topics including treatment, diet, exercise, trials here & abroad as well as support. Any age, any stage: facebook.com/groups/83038436… @RayMcDermott1 @MaterTrials @stjamesdublin @DrHealeyBird

Cancer Trials Mater avatar
Cancer Trials Mater@MaterTrials·24 Nov 2022

Fantastic news 🥳🎇🎉 Thank you to our patient who committed to this trial to prove that this drug is effective. #CancerResearch #ovariancancer #clinicaltrials #clinicaltrialsimprovepatientoutcomes

1st new treatment in 7 years for platinum resistant ovarian cancer approved by FDA, following international SORAYA trial including 6 🇮🇪 patients from Beaumont, Bons Cork (2), CUH, Mater & UH Waterford. Big shout out to Dr Conleth Murphy of @BonsCancerCork on this study 👏💪

Post attachment